M

Medicinova

MNOV

1.33000
USD
0
(0.00%)
Market Closed
Volume
1,243
EPS
0
Div Yield
0
P/E
-11
Market Cap
88,283,243
OverviewSignalsIdeasNews
Related Instruments
A
ABUS
0.03500
(0.93%)
3.80500 USD
A
ADAP
-0.05000
(-3.79%)
1.27000 USD
A
ALLO
-0.21500
(-7.29%)
2.73500 USD
A
ARCT
-1.880
(-8.01%)
21.600 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
D
DBVT
0.00290
(0.31%)
0.95000 USD
G
GTHX
-0.11000
(-2.56%)
4.19000 USD
I
IMV
0.01000
(1.96%)
0.51000 USD
M
MDGL
-6.22
(-2.18%)
278.97 USD
MRNA
-25.020
(-20.99%)
94.160 USD
N
NKTR
-0.10000
(-7.38%)
1.25500 USD
News

Novo Nordisk Surges in Profit and Sales

5 months ago
Stocks news

Title: Medicinova

Sector: Healthcare
Industry: Biotechnology
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.